Case Study for a Phase III Trial for a Large Pharmaceutical
Client: Large Pharmaceutical Company
Ask: Run the Latin American region for a pediatric phase III global trial.
Situation: The other global regions were struggling to hit enrollment targets due to a challenging patient population and inclusion/exclusion criteria.
PanAmerican Solution: Rather than select sites simply based on a potential productive patient database, PanAmerican opened sites in communities it identified as having a high disease incidence as determined through an extensive site network and community health screening events. To emphasize recruitment and participant engagement and to control GCP quality in such approach, PanAmerican embedded an experienced, medically and research trained study coordinator at each site.
PanAmerican Result: Latin America became the highest enrolling region in the global trial, in the least amount of time, with the fewest sites, and with no adverse audit findings.
“PanAmerican is our go to partner in the Southwest and Latin America and consistently outperforms all other regions for global trials – both in recruitment and quality of data.”
